- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.10. | Modular Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 28.10. | Modular Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.10. | Modular Medical, Inc.: Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification | 605 | ACCESS Newswire | Certification Represents Another Milestone Toward CE Mark Submission for Pivot SAN DIEGO, CA / ACCESS Newswire / October 27, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD)... ► Artikel lesen | |
| 15.10. | Modular Medical launches digital tools for insulin pump training | 2 | Investing.com | ||
| 15.10. | Modular Medical, Inc.: Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System | 283 | ACCESS Newswire | Game-Based Education Tools Designed to Help Improve Patient Familiarity with Pump Therapy and Support Healthcare Providers in Identifying Candidates for Pump Adoption SAN DIEGO, CA / ACCESS Newswire... ► Artikel lesen | |
| 07.10. | Modular Medical, Inc.: Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th | 301 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 29.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.09. | Modular Medical, Inc.: Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026 | 370 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.09. | Modular Medical Aktie steigt nach Vertrag mit führendem Pharmacy Benefit Manager | 2 | Investing.com Deutsch | ||
| 04.09. | Modular Medical sichert sich Vertrag mit landesweitem US-Apothekenmanager | 1 | Investing.com Deutsch | ||
| 04.09. | Modular Medical secures contract with national U.S. pharmacy manager | 2 | Investing.com | ||
| 04.09. | Modular Medical, Inc.: Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump | 490 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial... ► Artikel lesen | |
| 03.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Modular Medical, Inc.: Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements | 419 | ACCESS Newswire | Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the... ► Artikel lesen | |
| 03.09. | EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades | 2 | Benzinga.com | ||
| 02.09. | Modular Medical, Inc.: Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled 'The Road To Revenue: Modular Medical's Strategy For Launching Pivot' Featuring Modular Medical CEO - Friday, September 4, 2026 | 487 | ACCESS Newswire | Meet with Modular Medical CEO Jeb Besser.Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal... ► Artikel lesen | |
| 02.09. | 6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More | 1.029 | AFX News | BEIJING (dpa-AFX) - Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies... ► Artikel lesen | |
| 14.08. | Modular Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 444 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.08. | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 8,340 | -3,41 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| SERNOVA BIOTHERAPEUTICS | 0,070 | -0,57 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 0,688 | -32,68 % | Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall | ||
| ATOSSA THERAPEUTICS | 1,870 | -1,58 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 16,300 | -4,12 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,320 | -11,46 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile... ► Artikel lesen | |
| QUIDELORTHO | 11,565 | -9,54 % | QuidelOrtho expects over $80M in 2027 annual savings as it narrows 2026 revenue to $2.52B-$2.54B | ||
| VERU | 2,120 | -3,64 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,150 | 0,00 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,090 | -1,68 % | Needham reiterates Clover Health stock rating on profitability | ||
| SENSEONICS | 8,200 | +1,86 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| NANO-X IMAGING | 0,258 | -9,15 % | NANO-X IMAGING LTD: TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution | ||
| TEMPEST THERAPEUTICS | 0,425 | -8,37 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 0,790 | -2,47 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |
Das Unternehmen MODULAR MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,030 (+1,80 %) liegt der Kurs bei 1,700 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULAR MEDICAL INC finden Sie auf Wallstreet Online.